Journal of Clinical and Cellular Immunology : Citations & Metrics Report
Articles published in Journal of Clinical and Cellular Immunology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Cellular Immunology has got h-index 42, which means every article in Journal of Clinical and Cellular Immunology has got 42 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical and Cellular Immunology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
30 | 31 | 30 | 59 | 28 | 11 | 35 | 56 | 95 | 105 | 101 | 105 | 64 | 15 | 3 |
Research, Review articles and Editorials |
2 | 13 | 8 | 23 | 18 | 8 | 25 | 35 | 54 | 86 | 79 | 35 | 23 | 14 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 18 | 22 | 22 | 10 | 3 | 10 | 21 | 39 | 6 | 9 | 7 | 1 | 1 | 0 |
Conference proceedings |
0 | 16 | 15 | 6 | 0 | 98 | 178 | 206 | 171 | 160 | 195 | 156 | 74 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
653 | 826 | 931 | 1079 | 1018 | 971 | 871 | 851 | 753 | 550 | 276 | 145 | 43 | 40 | 0 |
| Journal total citations count | 8361 |
| Journal impact factor | 24.12 |
| Journal 5 years impact factor | 31.14 |
| Journal cite score | 30.45 |
| Journal h-index | 42 |
| Journal h-index since 2019 | 32 |
Important citations (1511)
gorosito serrán m, fiocca vernengo f, beccaria cg, acosta rodriguez ev, montes cl, et al.(2015) the regulatory role of b cells in autoimmunity, infections and cancer: perspectives beyond il10 production. febs letters 58:3362-9. |
|
zhang q, vignali da (2016) co-stimulatory and co-inhibitory pathways in autoimmunity. immunity 44:1034-51. |
|
zhang j, benedek g, bodhankar s, lapato a, vandenbark aa, et al. (2015) il-10 producing b cells partially restore e2-mediated protection against eae in pd-l1 deficient mice. journal of neuroimmunology 285:129-36. |
|
zhang j, lapato a, bodhankar s, vandenbark aa, offner h (2015) treatment with il-10 producing b cells in combination with e2 ameliorates eae severity and decreases cns inflammation in b cell-deficient mice. metabolic brain disease 30:1117-27. |
|
benedek g, zhang j, bodhankar s, nguyen h, kent g, et al. (2016) estrogen induces multiple regulatory b cell subtypes and promotes m2 microglia and neuroprotection during experimental autoimmune encephalomyelitis journal of neuroimmunology 293:45-53. |
|
ray a, wang l, dittel bn (2015) il-10-independent regulatory b-cell subsets and mechanisms of action. international immunology 27: 531-6. |
|
rincón-arévalo h, sanchez-parra cc, castaño d, yassin l, vásquez g (2016). regulatory b cells and mechanisms. international reviews of immunology 35:156-76. |
|
li p, mao l, liu x, gan y, zheng j, et al. (2014) essential role of program death 1-ligand 1 in regulatory t-cell–afforded protection against blood–brain barrier damage after stroke stroke 45:857-64. |
|
li yh, yu jw, xi jy, yu wb, liu jc, et al. (2016) fasudil enhances therapeutic efficacy of neural stem cells in the mouse model of mptp-induced parkinson’s disease molecular neurobiology 2:1-4. |
|
Rostami am. |
|
erkan ep, eren e, genc s, genc kk (2017) stem cell-based approaches for treatment of glioblastoma inneurological regeneration springer international publishing. |
|
Frey ii w. |
|
pahan k (2013) multiple sclerosis and experimental allergic encephalomyelitis. journal of clinical & cellular immunology 23:4. |
|
frey ii wh (2015) noninvasive intranasal stem cells bypass the blood-brain barrier to target the brain to treat parkinson's disease, stroke, ms, brain tumors, cerebral ischemia, alzheimer's and other cns disorders. journal of nature and science 1:23. |
|
wang x, yu x, vaughan w, liu m, guan y (2015) novel drug-delivery approaches to the blood-brain barrier. neuroscience bulletin 31:257-64. |
|
zhang c, cao j, li x, xu h, wang w, et al. (2016) treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells. science china life sciences 59: 950-7. |
|
pandey pk, sharma ak, gupta u (2016) blood brain barrier: an overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking. tissue barriers 4:e1129476. |
|
leovsky c, fabian c, naaldijk y, jäger c, jang hj,et al. (2015)biodistribution of in vitro–derived microglia applied intranasally and intravenously to mice: effects of aging. cytotherapy 17:1617-26. |
|
williams a (2015). remyelination in multiple sclerosis: what do we know and where are we going?. neurodegenerative disease management 5:49-59. |
|
linares gr, chiu ct, scheuing l, leng y, liao hm, et al. 2016) preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of huntington's disease. experimental neurology 281:81-92. |
|